1 completed, 1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Lakshmi N Yatham: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder psilocybin (25 mg), psilocybin 1mg micro-dose - Bipolar II Depression | Phase 2 | Recruiting | Lakshmi N Yatham | 90 | 2026-06-15 | 2026-09-15 |
| Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients Cariprazine, Placebo - Bipolar I Disorder, Cognitive Impairment | Phase 3 | Terminated | Lakshmi N Yatham | 1 | 2021-07-07 | 2024-10-26 |
| Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients lurasidone, Placebo - Bipolar Disorder | Phase 3 | Completed | Lakshmi N Yatham | 100 | 2017-05-08 | 2025-02-14 |
Bipolar Disorder (2) · Cognitive Dysfunction (1) · Depression (1) · Mood Disorders (1)
Lurasidone Hydrochloride (1) · Psilocybin (1) · cariprazine (1)
Canada (3) · Japan (1) · United Kingdom (1) · United States (1)